You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Haddadin Yezan Munther · SEC Form 4 · Filed Jun 3, 2026
Buy
Calculated transaction value
$24.15K
Haddadin Yezan Munther Director
OTLK
Outlook Therapeutics
OTLK
Transaction date
Jun 2, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 1 day later
OTLK daily price context
Close on/before transaction
$0.81
Jun 2, 2026
First close after public filing
$0.79
Jun 4, 2026
30-day return after filing
+78.66%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 29,000 shares @ $0.83
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001649989-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$24.15K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK Current | Buy | Jun 2, 2026 | $24.15K |